Lv4
660 积分 2021-03-30 加入
Topic: AS08-Treatment/AS08i-observational studies: REAL WORLD DATA CONFIRMS ACTIVITY OF LUSPATERCEPT IN HIGHER RISK AND HYPOMETHYLATING AGENTS-FAILED PATIENTS WITH MYELODYSPLASTIC SYNDROMES
8小时前
待确认
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts
9小时前
待确认
Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
2天前
已完结
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile
3天前
已完结
Early Observations on Effects of Mavacamten on Left Atrial Function in Obstructive Hypertrophic Cardiomyopathy Patients
3天前
已完结
Withdrawal of atrio-ventricular nodal blocking agents in patients receiving mavacamten: a retrospective single center experience in a predominantly Asian-American cohort
3天前
已完结
The Efficacy of Goal-Directed Valsalva to Elicit Clinically Significant Gradients in Patients with Obstructive Hypertrophic Cardiomyopathy taking Mavacamten Therapy
3天前
求助中
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile
3天前
已完结
Predictors of short-term and long-term effects of mavacamten in obstructive hypertrophic cardiomyopathy
3天前
已完结
皖公网安备34019202002308
